Note 4 - Other Financial Information (Tables)

3 Months Ended

Mar. 31, 2026

Notes Tables

Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]

		*March 31,*				*December 31,*
		*2026*				*2025*
Accounts payable		$	17,209			$	12,137
Accrued sales reserves			8,278				6,493
Accrued clinical expenses			2,627				2,364
Accrued research and development expenses			749				886
Accrued selling, general and administrative expenses			4,562				3,903
Accrued other expenses			1,921				1,934
Total accounts payable and accrued expenses		$	35,346			$	27,717

Interest Income and Interest Expense Disclosure [Table Text Block]

		*Three Months Ended March 31,*
		*2026*				*2025*
Interest income		$	931			$	2,204
Other loss, net			(323	)			(90	)
Total interest and other income, net		$	608			$	2,114